Related references
Note: Only part of the references are listed.Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells
Suzanne Reed et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Phase 1 Trial of Concurrent Erlotinib, Celecoxib, and Reirradiation for Recurrent Head and Neck Cancer
Johnny Kao et al.
CANCER (2011)
Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor-Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells
Yan Liu et al.
CANCER PREVENTION RESEARCH (2011)
Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cells
Cyril Sobolewski et al.
CELL CYCLE (2011)
Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells
Tae-Ho Kim et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
Fragment-Based Drug Design and Drug Repositioning Using Multiple Ligand Simultaneous Docking (MLSD): Identifying Celecoxib and Template Compounds as Novel Inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3)
Huameng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Inhibitory effect of celecoxib in lung carcinoma by regulation of cyclooxygenase-2/cytosolic phospholipase A2 and peroxisome proliferator-activated receptor gamma
Ming Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Phase I clinical trial of nasopharyngeal radiotherapy and concurrent celecoxib for patients with locoregionally advanced nasopharyngeal carcinoma
Wei-Ping Xue et al.
ORAL ONCOLOGY (2011)
Celecoxib Enhances Radiation Response of Secondary Bone Tumors of a Human Non-Small Cell Lung Cancer via Antiangiogenesis In Vivo
Frank Michael Klenke et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2011)
Anti-cancer effects of celecoxib on nasopharyngeal carcinoma HNE-1 cells expressing COX-2 oncoprotein
Jiongyu Chen et al.
CYTOTECHNOLOGY (2010)
STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling
Zhenlian Wang et al.
EUROPEAN JOURNAL OF CANCER (2010)
gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
Julia Bollrath et al.
CANCER CELL (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells
Vivian W. Y. Lui et al.
CARCINOGENESIS (2009)
STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro
Vivian Wai Yan Lui et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells
Xuechi Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax
Rene Handrick et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt
Bing Liu et al.
CELL BIOLOGY INTERNATIONAL (2008)
Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: The relation to STAT3 activation and EGFR expression
Ning Ma et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Nasopharyngeal carcinoma: Current management, future directions and dental implications
Mark Agulnik et al.
ORAL ONCOLOGY (2008)
Celecoxib toxicity is cell cycle phase specific
Jonathan M. Bock et al.
CANCER RESEARCH (2007)
Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer
Marjan Berishaj et al.
BREAST CANCER RESEARCH (2007)
Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation
Kwang Woon Kim et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors
Sabine Groesch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Knockdown of Stat3 expression using RNAi in hibits growth of laryngeal tumors in vivo
LF Gao et al.
ACTA PHARMACOLOGICA SINICA (2006)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
M Kortylewski et al.
NATURE MEDICINE (2005)
被撤回的出版物: Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with lymph node metastasis (Retracted Article. See vol 42, pg 653, 2006)
JP Peng et al.
ORAL ONCOLOGY (2005)
Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression
CML Chan et al.
BIOMEDICINE & PHARMACOTHERAPY (2005)
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
Q Xu et al.
ONCOGENE (2005)
Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: Clinical and in vitro studies
WC Chen et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2005)
Celecoxib inhibits prostate cancer growth: Evidence of a cyclooxygenase-2-independent mechanism
MI Patel et al.
CLINICAL CANCER RESEARCH (2005)
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells
GD Basu et al.
BREAST CANCER RESEARCH (2005)
Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis
TX Xie et al.
ONCOGENE (2004)
Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression
RJ Levitt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Epidemiology of nasopharyngeal carcinoma
MC Yu et al.
SEMINARS IN CANCER BIOLOGY (2002)
The significance of LMP1 expression in nasopharyngeal carcinoma
SW Tsao et al.
SEMINARS IN CANCER BIOLOGY (2002)
Epstein-Barr virus in the pathogenesis of NPC
N Raab-Traub
SEMINARS IN CANCER BIOLOGY (2002)
Phosphatidylinositol 3-kinase activity negatively regulates stability of cyclooxygenase 2 mRNA
MM Monick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line
S Arico et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells
S Murono et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression
PK Epling-Burnette et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
